Iron dextran
Ferric Oxyhydroxide, Ferrlecit, Infed, Velphoro, Venofer (iron dextran) is an unknown pharmaceutical. Iron dextran was first approved as Infed on 1982-01-01.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| ferrlecit | New Drug Application | 2025-06-06 |
| infed | New Drug Application | 2024-10-14 |
| iron dextran | New Drug Application | 2025-01-08 |
| venofer | New Drug Application | 2022-07-25 |
| venofer (iron sucrose) | New Drug Application | 2024-04-19 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Ferric Oxyhydroxide, Velphoro, Vifor Fresenius | |||
| 10624855 | 2034-11-26 | DP | |
| 11234938 | 2034-11-26 | DP | |
| 11446252 | 2034-11-26 | DP | |
| 9561251 | 2030-01-23 | DP | U-1468 |
| 10682376 | 2028-11-13 | DP | |
| 10695367 | 2028-11-13 | DP | |
| 10925896 | 2028-11-13 | DP | |
| 10925897 | 2028-11-13 | DP | |
| 10933090 | 2028-11-13 | DP | |
| 11013761 | 2028-11-13 | DP | |
| 11013762 | 2028-11-13 | DP | |
ATC Codes
No data
HCPCS
Code | Description |
|---|---|
| J1750 | Injection, iron dextran, 50 mg |
Clinical
Clinical Trials
2369 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Iron overload | D019190 | — | — | 2 | 17 | 7 | 14 | 6 | 44 |
| Thalassemia | D013789 | EFO_1001996 | D56 | 1 | 9 | 4 | 9 | 2 | 25 |
| Myelodysplastic syndromes | D009190 | — | D46 | — | 11 | — | 6 | 3 | 20 |
| Preleukemia | D011289 | — | — | — | 9 | — | 6 | 3 | 18 |
| Beta-thalassemia | D017086 | Orphanet_848 | D56.1 | 1 | 6 | 3 | 5 | 1 | 16 |
| Syndrome | D013577 | — | — | — | 7 | — | 6 | 2 | 15 |
| Anemia | D000740 | EFO_0004272 | D64.9 | 1 | 5 | 1 | 5 | 2 | 14 |
| Hemochromatosis | D006432 | EFO_1000642 | E83.11 | 1 | 6 | 2 | 4 | 1 | 13 |
| Hemosiderosis | D006486 | — | — | 1 | 6 | 2 | 4 | 1 | 13 |
| Sickle cell anemia | D000755 | EFO_0000697 | D57 | — | 3 | 2 | 1 | 3 | 9 |
Show 4 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 1 | 1 | 1 | — | — | 2 |
| Myeloid leukemia | D007951 | — | C92 | 1 | 1 | 1 | — | — | 2 |
| Porphyria cutanea tarda | D017119 | — | E80.1 | — | — | 1 | — | — | 1 |
| Erythropoietic porphyria | D017092 | — | — | — | — | 1 | — | — | 1 |
| Porphyrias | D011164 | EFO_0000665 | — | — | — | 1 | — | — | 1 |
| Hepatic porphyrias | D017094 | — | — | — | — | 1 | — | — | 1 |
| Primary myelofibrosis | D055728 | — | D47.4 | — | — | 1 | — | — | 1 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | — | — | 1 | — | — | 1 |
| Philadelphia chromosome | D010677 | — | — | — | — | 1 | — | — | 1 |
| Hepatitis b | D006509 | — | — | — | — | 1 | — | — | 1 |
Show 2 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Mucormycosis | D009091 | EFO_0007380 | B46.5 | — | 1 | — | — | — | 1 |
| Zygomycosis | D020096 | — | B46 | — | 1 | — | — | — | 1 |
| Hemolytic anemia | D000743 | — | D55-D59 | — | 1 | — | — | — | 1 |
| Fanconi anemia | D005199 | Orphanet_84 | D61.03 | — | 1 | — | — | — | 1 |
| Fanconi syndrome | D005198 | — | — | — | 1 | — | — | — | 1 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | 1 | — | — | — | — | 1 |
| Hepatic insufficiency | D048550 | — | — | 1 | — | — | — | — | 1 |
| Iron-deficiency anemia | D018798 | — | D50 | 1 | — | — | — | — | 1 |
| Iron deficiencies | D000090463 | — | E61.1 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Thrombocytopenia | D013921 | HP_0001873 | D69.6 | — | — | — | — | 1 | 1 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | — | 1 | 1 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | — | — | — | 1 | 1 |
| Fatty liver | D005234 | EFO_0003934 | — | — | — | — | — | 1 | 1 |
| Myelomonocytic leukemia chronic | D015477 | — | C93.1 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Iron dextran |
| INN | — |
| Description | Iron supplements, also known as iron salts and iron pills, are a number of iron formulations used to treat and prevent iron deficiency including iron deficiency anemia. For prevention they are only recommended in those with poor absorption, heavy menstrual periods, pregnancy, hemodialysis, or a diet low in iron. Prevention may also be used in low birth weight babies. They are taken by mouth, injection into a vein, or injection into a muscle. While benefits may be seen in days, up to two months may be required until iron levels return to normal.
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 10028-22-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201544 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Iron dextran
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 5,529 documents
View more details
Safety
Black-box Warning
Black-box warning for: Iron dextran
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
9,774 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use